Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lucid Diagnostics Inc (NQ: LUCD ) 0.8101 -0.0199 (-2.40%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Lucid Diagnostics Inc < Previous 1 2 3 4 Next > 12 Health Care Stocks Moving In Wednesday's After-Market Session February 02, 2022 Gainers Syros Pharmaceuticals (NASDAQ:SYRS Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 19, 2022 Gainers Zogenix (NASDAQ:ZGNX) stock rose 68.2% to $26.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.4 billion. Lucid... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday January 19, 2022 Good morning, investor! We're diving right into trading today with a look at the biggest pre-market stock movers for Wednesday! Via InvestorPlace 20 Stocks Moving in Wednesday's Pre-Market Session January 19, 2022 Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares rose 56.1% to $24.41 in pre-market trading after UCB announced plans to acquire the company. Fresh Vine Wine, Inc. (NYSE: VINE) rose... Via Benzinga Analyst Ratings For Lucid Diagnostics December 27, 2021 Lucid Diagnostics (NASDAQ:LUCD) has observed the following analyst ratings ... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session January 14, 2022 Gainers Avinger (NASDAQ:AVGR) stock moved... Via Benzinga PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team January 12, 2022 From PAVmed Inc. and Lucid Diagnostics Inc. Via Business Wire 10 Low-Float Penny Stocks for Steel-Gutted Investors January 11, 2022 If you’re willing to absorb massive risk for the chance of significant upside, these low-float penny stocks could fit the bill. Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session January 10, 2022 Gainers Inari Medical (NASDAQ:NARI) stock... Via Benzinga Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference January 06, 2022 From Lucid Diagnostics Inc. Via Business Wire 34 Stocks Moving In Monday's Mid-Day Session December 27, 2021 Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY... Via Benzinga 51 Biggest Movers From Yesterday December 28, 2021 Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session December 27, 2021 Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 55.35% to $8.42 during Monday's pre-market session. The company's market cap stands at $59.8 million... Via Benzinga PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth December 01, 2021 From Lucid Diagnostics Inc. Via Business Wire 61 Biggest Movers From Yesterday November 18, 2021 Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped... Via Benzinga Topics Initial Public Offering Exposures Securities Market 42 Stocks Moving In Wednesday's Mid-Day Session November 17, 2021 Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares climbed... Via Benzinga Topics Initial Public Offering Exposures Securities Market Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum November 17, 2021 From Lucid Diagnostics Inc. PAVmed Inc. Via Business Wire PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results November 16, 2021 From PAVmed Inc. and Lucid Diagnostics Inc. Via Business Wire PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers November 11, 2021 From Lucid Diagnostics Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021 November 08, 2021 Upgrades For Nektar Therapeutics (NASDAQ: Via Benzinga PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021 November 03, 2021 From PAVmed Inc. and Lucid Diagnostics Inc. Via Business Wire The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More November 08, 2021 Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... Via Benzinga Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award October 28, 2021 From Lucid Diagnostics Inc. Via Business Wire ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer October 21, 2021 From Lucid Diagnostics Inc. Via Business Wire Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer October 21, 2021 From Lucid Diagnostics Inc. Via Business Wire 3 Stocks Insiders Are Buying October 21, 2021 When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... Via Benzinga Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering October 18, 2021 From Lucid Diagnostics Inc. Via Business Wire 51 Biggest Movers From Friday October 18, 2021 Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it... Via Benzinga LUCD Stock IPO: 7 Things to Know as Lucid Diagnostics Starts Trading Today October 14, 2021 Unfortunately, today is a very red day for investors who got in on the recent LUCD stock IPO, with shares of this stock down more than 17%. Via InvestorPlace Topics Initial Public Offering Exposures Securities Market The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts October 14, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Catalyst Biosciences Announces Resignation Of CFO Catalyst Biosciences, Inc... Via Benzinga Exposures COVID-19 < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.